SORL1 and Alzheimer disease: Surprisingly, recent studies now suggest that noncoding risk SNPs in SORL1 may not impact receptor expression in neurons, but in microglia, arguing for an important function of the receptor in this cell type in the context of AD (Nott et al. 2019).